Fortress Biotech, Inc.
FBIO
$2.31
$0.093.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.24M | 59.29M | 56.90M | 56.78M | 56.68M |
| Total Other Revenue | 2.02M | 3.01M | 2.40M | 1.00M | 1.00M |
| Total Revenue | 63.26M | 62.30M | 59.30M | 57.78M | 57.68M |
| Cost of Revenue | 32.83M | 42.38M | 50.33M | 55.66M | 77.78M |
| Gross Profit | 30.43M | 19.93M | 8.97M | 2.12M | -20.10M |
| SG&A Expenses | 96.57M | 108.70M | 113.28M | 95.34M | 87.62M |
| Depreciation & Amortization | 4.26M | 4.17M | 3.92M | 3.67M | 3.42M |
| Other Operating Expenses | -- | -4.55M | -4.55M | -4.55M | -4.55M |
| Total Operating Expenses | 133.65M | 150.70M | 162.98M | 150.13M | 164.27M |
| Operating Income | -70.39M | -88.39M | -103.68M | -92.34M | -106.59M |
| Income Before Tax | -33.71M | -53.47M | -88.95M | -106.12M | -120.45M |
| Income Tax Expenses | -790.00K | 362.00K | 405.00K | 405.00K | 405.00K |
| Earnings from Continuing Operations | -32.92 | -53.83 | -89.35 | -106.52 | -120.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 39.73M | 57.82M | 74.62M | 65.36M | 74.86M |
| Net Income | 6.82M | 3.99M | -14.73M | -41.16M | -46.00M |
| EBIT | -70.39M | -88.39M | -103.68M | -92.34M | -106.59M |
| EBITDA | -65.73M | -83.76M | -99.25M | -87.88M | -102.13M |
| EPS Basic | -0.05 | -0.22 | -1.12 | -2.34 | -2.90 |
| Normalized Basic EPS | 0.42 | 0.65 | 0.18 | 0.16 | 0.16 |
| EPS Diluted | -0.12 | -0.29 | -1.17 | -2.35 | -2.91 |
| Normalized Diluted EPS | 0.33 | 0.56 | 0.17 | 0.16 | 0.16 |
| Average Basic Shares Outstanding | 110.96M | 106.59M | 99.04M | 90.48M | 81.18M |
| Average Diluted Shares Outstanding | 119.76M | 115.39M | 101.98M | 90.48M | 81.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | -4.88% | -8.73% |